InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ANTX
Result 27 decisions over 120 months
Reset filters
Direction ?
Both27 Bought11 Sold16
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ANTX Plan: Not stated
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ANTX AN2 Therapeutics, Inc.
14 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
23
$345.92
0.5%
ANTX AN2 Therapeutics, Inc.
10 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
4,413
$67.63K
47.2%
ANTX AN2 Therapeutics, Inc.
9 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
10,111
$157.85K
67.3%
ANTX AN2 Therapeutics, Inc.
8 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
7,055
$109.95K
32.0%
ANTX AN2 Therapeutics, Inc.
7 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
12,203
$195.74K
71.3%
ANTX AN2 Therapeutics, Inc.
4 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
8,828
$139.47K
34.0%
ANTX AN2 Therapeutics, Inc.
3 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
14,165
$223.06K
35.3%
ANTX AN2 Therapeutics, Inc.
2 Nov 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
1,544
$23.26K
23.9%
ANTX AN2 Therapeutics, Inc.
31 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
2,688
$41.36K
29.4%
ANTX AN2 Therapeutics, Inc.
28 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
1,683
$25.39K
25.5%
ANTX AN2 Therapeutics, Inc.
27 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
924
$14.19K
12.3%
ANTX AN2 Therapeutics, Inc.
26 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
1,678
$25.34K
25.5%
ANTX AN2 Therapeutics, Inc.
25 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
4,806
$75.67K
42.2%
ANTX AN2 Therapeutics, Inc.
24 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated
2,866
$46.34K
20.1%
ANTX AN2 Therapeutics, Inc.
21 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
13,951
$228.24K
74.0%
ANTX AN2 Therapeutics, Inc.
20 Oct 2022
Easom Eric
Chief Executive Officer
Sold, plan not stated 2×
7,293
$121.67K
27.9%
ANTX AN2 Therapeutics, Inc.
4 Aug 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
100
$799.00
0.0%
ANTX AN2 Therapeutics, Inc.
3 Aug 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
1,809
$13.53K
0.0%
ANTX AN2 Therapeutics, Inc.
27 Jul 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
8,281
$65.50K
0.2%
ANTX AN2 Therapeutics, Inc.
26 Jul 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
14,938
$115.17K
0.4%
ANTX AN2 Therapeutics, Inc.
21 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
302
$2.41K
0.0%
ANTX AN2 Therapeutics, Inc.
14 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
61,424
$489.40K
1.7%
ANTX AN2 Therapeutics, Inc.
13 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
20,000
$158.00K
0.5%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought 2×
1,666,666
$25.00M
105%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Aziz Kabeer
Director indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Adjuvant Global Health Technology Fund, L.P.
10% owner indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Readnour Robin Shane
Director indirect
Bought 2×
153,334
$2.30M
45.9%
Showing 1–27 of 27.